For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Overcoming statin reluctance in people managing their health the natural way
+Practice
In print
HEARTBEAT
Overcoming statin reluctance in people managing their health the natural way
Wednesday 10 November 2021, 12:30 AM

Consultant cardiologist Chris Ellis discusses a patient who has steadfastly declined any offer of drug management for his hypertension and dyslipidaemia. A heart attack and some gentle explanations change his view
Key points, Some patients may believe statin drugs are bad for them and refuse to take them.
Statins “stabilise” the fatty, soft atherosclerosis within the arte, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.